Clinical Trial Update: IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is investigating interferon-gamma combined with T cells for refractory malignant pleural effusion (and ascites) and is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Effusion

Drugs mentioned

• Interferon-gamma (interferon gamma)
• T cells (adoptive cell therapy) (T cells)

Snippet

Sponsor: Affiliated Hospital of Jiangnan University | Conditions: Pleural Effusion, Malignant | Phase 1 | Status: RECRUITING